Clinical trial
Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory…
NCT00215709 · Geriatric Oncology Consortium, Other · Completed
Key facts
| NCT number | NCT00215709 |
|---|---|
| Title | Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer |
| Official title | A Pilot Study of Docetaxel on a Bi-Weekly Schedule in the Treatment of Elderly Men With Hormone-Refractory Prostate Cancer (HRPC) |
| Lead sponsor | Geriatric Oncology Consortium, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | docetaxel |
| Enrollment | 17 |
| Start date | Jul 1, 2004 |
| Completion | Jul 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 19, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: